Working with mice, hamsters, and nonhuman primates, Penn researchers found that a modified version of the mRNA COVID-19 ...
StudyFinds on MSN15d
Repurposed cancer vaccine stops early-stage tumors from growing, study revealsRather than discarding a failed cancer treatment, scientists are getting a second chance to test this vaccine on newly ...
MacMaster, Ph.D., associate professor of Microbiology-Immunology, have discovered that administering an antibody treatment ...
Cleveland Clinic researchers are presenting updated findings from their novel study of a vaccine aimed at preventing ...
The vaccine, which blocks a protein believed ... more than doubled compared to when no measures were taken. In the cases of vaccinated mice, the brain’s areas atrophied by dementia were only ...
Gentle nasal spray vaccines against COVID, the flu and RSV are coming. They may work better than shots in the arm ...
Systemic reactions occurred in 2–3% of those vaccinated and ... Evaluation in mice showed the immunogenic properties of this type of inactivated vaccine. This bivalent vaccine started to be ...
Working with animals, Penn researchers modified the mRNA vaccine to target C. difficile, an infection that kills 30,000 in ...
Vaccinated mice even survived a second infection six months later. A version of the vaccine that also targeted its spores appeared to prime mice and nonhuman primates to fight off C. diff infections.
Vaccinated mice even survived a second infection six months later. A version of the vaccine that also targeted its spores appeared to prime mice and nonhuman primates to fight off C. diff infections.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback